Learn about the basic science of genetics, how treatments and medicines are being applied based on genetic testing, and how it relates to the African American Myeloma Community. Why is is important to know and what should you do with this knowledge? Come with your questions.
“I became a Myeloma Coach after meeting many patients who did not have a peer mentor to ask questions and find relevant information about myeloma.”
Scott R. Goldsmith MD specializes in the treatment of multiple myeloma, which is also the focus of his prolific research. “I am passionate about bringing new and innovative treatments to patients with multiple myeloma and other hematologic malignancies through translational research and clinical trials,” he said. Dr. Goldsmith entered medicine because he remembers how well he was treated when he was a patient in his teen years. “I felt firsthand the profound, lasting impact that healthcare professionals can have on an individual,” he recalled. He credits that experience with informing the way he practices medicine today: “To listen carefully, communicate clearly, and understand who my patients are as people.” A Florida native, Dr. Goldsmith graduated with honors from the University of Florida – Gainesville, FL, then earned his medical degree at UF’s College of Medicine and continued his training at Barnes-Jewish Hospital, Washington University School of Medicine – St. Louis, MO. Dr. Goldsmith takes pride in the relationships he forms with his patients, and he is intent on making an impact “at an individual, institutional, and global level” in finding better treatments for multiple myeloma. He feels City of Hope, with its “bench to bedside” philosophy, is the ideal place to be. “I feel really fortunate to become a part of this institution and contribute to these missions.”
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
+1 800 709 1113
Support@healthtree.org
Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.